The study is a multicentre study performed at three Swedish clinics. It is a continuation of a previous study ("No implant migration and good subjective outcome of a novel customized femoral resurfacing metal implant for focal chondral lesions") by A. Stålman et al., published in the scientific journal Knee Surgery, Sports Traumatology, Arthroscopy in 2018.
The patients in the study received an Episealer® Knee implant as treatment of a focal cartilage defect in the knee during
"This is the first clinical study with 5-7 years' follow up from the use of the Episealer® knee implants. The fact that the positive results that are shown at the 24 months' follow-up remain over time, points to the conclusion that our technology is not only a temporary solution. Stakeholders, including our customers, insurance companies and healthcare providers, have requested this type of clinical evidence before approving the Episealer® technology within their standard treatment algorithm. We are delighted to hear about the positive results from this independent study, and we hope to see these results published shortly", says Pål Ryfors, CEO,
"This news is superbly satisfactory. Not only does the Episealer® technology show very low revision rates, as previously disclosed, but good clinical results also remain over time which is another imperative characteristic of any excellent medical technology", says Prof.
For more information, please contact:
Pål Ryfors, CEO,
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About
This information is information that
https://news.cision.com/episurf/r/positive-results-from-5-7-years--follow-up-of-the-first-episealer--knee-patients-in-a-swedish-multic,c3190616
https://mb.cision.com/Main/14691/3190616/1303896.pdf
(c) 2020 Cision. All rights reserved., source